tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market

ImmunityBio (IBRX) Technical Analysis

Compare
1,450 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
ImmunityBio’s (IBRX) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting ImmunityBio is a Buy.
ImmunityBio’s (IBRX) 20-Day exponential moving average is 2.78, while ImmunityBio’s (IBRX) share price is $2.72, making it a Sell.
ImmunityBio’s (IBRX) 50-Day exponential moving average is 2.78, while ImmunityBio’s (IBRX) share price is $2.72, making it a Sell.

ImmunityBio (IBRX) Pivot Points

Jul 06, 2025, 05:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.32
2.43
2.54
2.65
2.76
2.87
2.98
Fibonacci
2.43
2.52
2.57
2.65
2.74
2.79
2.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ImmunityBio (IBRX) Moving Averages

Jul 06, 2025, 05:43 PM
Period
Simple
Exponential
MA5
2.65Buy
2.68Buy
MA10
2.72Sell
2.73Sell
MA20
2.92Sell
2.78Sell
MA50
2.68Buy
2.78Sell
MA100
2.82Sell
2.90Sell
MA200
3.31Sell
3.38Sell
ImmunityBio’s (IBRX) 10-Day exponential moving average is 2.73, while ImmunityBio’s (IBRX) share price is $2.72, making it a Sell.
ImmunityBio’s (IBRX) 100-Day exponential moving average is 2.90, while ImmunityBio’s (IBRX) share price is $2.72, making it a Sell.
ImmunityBio’s (IBRX) stock price is $2.72 and ImmunityBio’s (IBRX) 50-day simple moving average is 2.68, creating a Buy signal.
ImmunityBio’s (IBRX) stock price is $2.72 and ImmunityBio’s (IBRX) 100-day simple moving average is 2.82, creating a Sell signal.
ImmunityBio’s (IBRX) stock price is $2.72 and ImmunityBio’s (IBRX) 200-day simple moving average is 3.31, creating a Sell signal.

ImmunityBio (IBRX) Technical Indicators

Jul 06, 2025, 05:43 PM
Name
Value
Implied Action
RSI (14)
47.23
Neutral
STOCH (9,6)
35.74
Neutral
STOCHRSI (14)
17.90
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
18.19
Buy
Williams %R
-70.27
Buy
CCI (14)
-71.13
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
41.02
Neutral
ROC
-14.73
Sell
ImmunityBio’s (IBRX) Relative Strength Index (RSI) is 47.23, creating a Neutral signal.
ImmunityBio’s (IBRX) Trend Strength Indicator (ADX) is 18.19, creating a Buy signal.
ImmunityBio’s (IBRX) Commodity Channel Index (CCI) is -71.13, creating a Neutral signal.
ImmunityBio’s (IBRX) Price Rate of Change (ROC) is -14.73, creating a Sell signal.

FAQ

Is IBRX a Buy, Hold, or Sell?
Based on IBRX’s technical indicators, IBRX is a Sell.
    What is IBRX’s RSI (14)?
    IBRX’s RSI (14) is 47.23, which suggests IBRX is a Neutral.
      What is IBRX’s MACD?
      IBRX’s MACD is -0.03, which suggests IBRX is a Buy.
        What is IBRX’s 5-day moving average?
        IBRX’s 5-day moving average is 2.65, which suggests IBRX is a Buy.
          What is IBRX’s 20-day moving average?
          IBRX 20-day moving average is 2.92, which suggests IBRX is a Sell.
            What is IBRX’s 50-day moving average?
            IBRX’s 50-day moving average is 2.68, which suggests IBRX is a Buy.
              What is IBRX’s 200-day moving average?
              IBRX’s 200-day moving average is 3.31, which suggests IBRX is a Sell.
                What is IBRX’s Williams % R (14)?
                IBRX’s Williams % R (14) is -70.27, which suggests IBRX is a Buy.
                  What is IBRX’s CCI (14)?
                  IBRX’s CCI (14) is -71.13, which suggests IBRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis